Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LL
3301
DELISTED
LL Flooring Holdings, Inc.
LL
| $2.28M | ﹤0.01% |
594,024
+233,523
| +65% | +$903K |
|
3302
ESCO Technologies
ESE
$8.17B
| $2.27M | ﹤0.01% |
21,952
+9,062
| +70% | +$871K |
|
3303
PUT
PennyMac Financial
PFSI
$3.92B
| $2.27M | ﹤0.01% |
+32,300
| New | +$2.05M |
|
3304
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $2.27M | ﹤0.01% |
41,647
-63,913
| -61% | -$3.46M |
|
3305
CALL
HF Sinclair
DINO
$16.3B
| $2.26M | ﹤0.01% |
+50,700
| New | +$2.21M |
|
|
3306
PUT
HF Sinclair
DINO
$16.3B
| $2.26M | ﹤0.01% |
50,700
-20,300
| -29% | -$884K |
|
3307
Upwork
UPWK
$1.13B
| $2.26M | ﹤0.01% |
242,066
-44,135
| -15% | -$400K |
|
3308
Prothena Corp
PRTA
$425M
| $2.26M | ﹤0.01% |
33,100
-161,539
| -83% | -$10.4M |
|
|
PGRE
3309
DELISTED
Paramount Group
PGRE
| $2.26M | ﹤0.01% |
510,074
+468,351
| +1,123% | +$2.08M |
|
3310
CALL
Surgery Partners
SGRY
$2.01B
| $2.25M | ﹤0.01% |
+50,000
| New | +$1.91M |
|
3311
CALL
Revolution Medicines
RVMD
$39.9B
| $2.25M | ﹤0.01% |
+84,000
| New | +$2.06M |
|
3312
Sonoco
SON
$5.57B
| $2.24M | ﹤0.01% |
37,928
+19,504
| +106% | +$1.17M |
|
|
YMAB
3313
DELISTED
Y-mAbs Therapeutics
YMAB
| $2.24M | ﹤0.01% |
329,569
-293,522
| -47% | -$2.2M |
|
3314
Pathward Financial
CASH
$1.86B
| $2.23M | ﹤0.01% |
48,155
-12,679
| -21% | -$569K |
|
3315
Ituran Location and Control
ITRN
$1.09B
| $2.23M | ﹤0.01% |
95,593
+28,045
| +42% | +$632K |
|
3316
CALL
Dollar General
DG
$28B
| $2.22M | ﹤0.01% |
13,100
-69,600
| -84% | -$13.8M |
|
|
WBA
3317
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $2.22M | ﹤0.01% |
78,000
-437,200
| -85% | -$14.2M |
|
3318
Atmus Filtration Technologies
ATMU
$4.22B
| $2.22M | ﹤0.01% |
+101,183
| New | +$2.12M |
|
|
FRBN
3319
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $2.22M | ﹤0.01% |
207,000
| – | – |
|
3320
Albemarle
ALB
$13.9B
| $2.22M | ﹤0.01% |
9,941
-439,745
| -98% | -$89.9M |
|
3321
PUT
Bruker
BRKR
$9.57B
| $2.22M | ﹤0.01% |
30,000
| – | – |
|
3322
Aon
AON
$76.5B
| $2.22M | ﹤0.01% |
6,422
-101,100
| -94% | -$32.8M |
|
3323
BILL Holdings
BILL
$4.49B
| $2.22M | ﹤0.01% |
18,970
+680
| +4% | +$64.6K |
|
3324
Goosehead Insurance
GSHD
$2.2B
| $2.22M | ﹤0.01% |
35,240
-75,846
| -68% | -$4.36M |
|
3325
AAR Corp
AIR
$5.59B
| $2.22M | ﹤0.01% |
38,366
-8,428
| -18% | -$454K |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.